BioLight (“the Company”) hereby announce that on March 25, 2019, according to the immediate report of Micromedic Technologies Ltd. (“Micromedic”), an investee company controlled by the Company, Micromedic entered into a non-binding memorandum of understanding with Nexstage Cannabis Innovation Ltd. (“Nexstage”, for information on Nexstage, see Section 6 of the Micromedic Report) and with the shareholders of Nexstage (the “Non-binding MOU”), under which, subject to the signing of a detailed agreement between the parties and the fulfillment of preconditions, a merger transaction will be executed between Micromedic and Nexstage (“The merger transaction”).
Link to Newsroom